Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2003
Pharmacodynamics of selective androgen receptor modulatorsDonghua Yin, Wenqing Gao, Jeffrey D Kearbey, et al.
International Journal of Cancer|August 24, 2012
Role and pharmacologic significance of cytochrome P-450 2D6 in oxidative metabolism of toremifene and tamoxifenJuhyun Kim, Christopher C Coss, Christina M Barrett, et al.
Expert Opinion on Therapeutic Patents|March 23, 2010
Estrogen receptor beta selective nonsteroidal estrogens: seeking clinical indicationsMichael L Mohler, Ramesh Narayanan, Christopher C Coss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate CancerSuriyan Ponnusamy, Yali He, Dong-Jin Hwang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2022
Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancerThirumagal Thiyagarajan, Suriyan Ponnusamy, Dong-Jin Hwang, et al.
Cancer Research|October 6, 2017
Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate CancerSuriyan Ponnusamy, Christopher C Coss, Thirumagal Thiyagarajan, et al.
Plant Biotechnology Journal|September 18, 2020
Genomic analyses of diverse wild and cultivated accessions provide insights into the evolutionary history of jujubeMingxin Guo, Zhongren Zhang, Shipeng Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 12, 2026
ALKBH3 m1A Demethylase Deficiency Reduces Alzheimer's Amyloid-β PathologyYueyang Li, Sifei Yu, Kaidong Lu, et al.
Pageof 6